Unknown

Dataset Information

0

YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma.

ABSTRACT:

SUBMITTER: Shan H 

PROVIDER: S-EPMC7338474 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma.

Shan Huizhuang H   Cao Yang Y   Xiao Xinhua X   Liu Meng M   Wu Yunzhao Y   Zhu Qi Q   Xu Hanzhang H   Lei Hu H   Yao Zhujun Z   Wu Yingli Y  

Signal transduction and targeted therapy 20200706 1

Similar Datasets

Unknown Apatinib enhances chemosensitivity of ABT-199 in diffuse large B-cell lymphoma.
| S-EPMC9580892 | biostudies-literature
Unknown Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cells.
| S-EPMC3817219 | biostudies-literature
Unknown SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
| S-EPMC6998659 | biostudies-literature
Transcriptomics Comparing gene expression in ABT-199 (venetoclax) sensitive and resistant diffuse large B cell lymphoma cell (DLBCL) lines
2024-06-20 | GSE252306 | GEO
Unknown BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
| S-EPMC6945775 | biostudies-literature
Unknown Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivo.
| S-EPMC5808038 | biostudies-literature
Unknown IBtkα Activates the β-Catenin-Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3β in Cancerous B Cells.
| S-EPMC8875111 | biostudies-literature
Unknown Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins.
| S-EPMC6697639 | biostudies-literature
Unknown Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.
| S-EPMC6237582 | biostudies-literature
Unknown The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells.
| S-EPMC6327051 | biostudies-literature